home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Genetic News | search  
 

Hypermutation Linked To ‘B-Cell Diffuse Large-Cell’ Non-Hodgkin’s Lymphoma Formation

 
  July, 19 2001 23:57
your information resource in human molecular genetics
 
     
ALL CHANGE

A natural mechanism for fine-tuning our immune response to disease may underlie the development of a form of non-Hodgkin’s lymphoma affecting B cells, report Riccardo Dalla-Favera at Columbia University in New York and colleagues in this week’s Nature (Vol. 412, No. 6844, 19 Jul 2001).

While they are developing, regions of the DNA of antibody-producing B cells undergo a process called ‘hypermutation’ to generate a range of antibody types. Dalla-Favera’s group screened the DNA of B cells from over 100 patients with ‘B-cell diffuse large-cell’ non-Hodgkin’s lymphoma. They found that this hypermutation mechanism has escaped the confines of the region that codes for antibodies, and now causes hypermutation of other genes - including four genes known to be associated with cancerous B cells. Hypermutation of these genes is likely to lead to the formation of this specific type of B-cell lymphoma, the researchers conclude.

CONTACT:

Riccardo Dalla-Favera
el +1 212 304 7380
e-mail rd10@columbia.edu

(C) Nature press release.


Message posted by: Trevor M. D'Souza

print this article mail this article
Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2018 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.